Leuprolide Acetate Long-Acting Suspension for Intramuscular Injection Shortage

• • Abbvie states Lupron Depot was on shortage due to a routine manufacturing compliance review.
  • Lupron Depot-Ped products are not included in this posting.

• • Lupron Depot intramuscular powder for suspension for injection, AbbVie, 11.25 mg (3 month), single dose administration kit, dual chamber prefilled syringe, 1 count, NDC 00074-3663-03
  • Lupron Depot intramuscular powder for suspension for injection, AbbVie, 3.75 mg (1 month), single dose administration kit, dual chamber prefilled syringe, 1 count, NDC 00074-3641-03
  • Lupron Depot intramuscular powder for suspension for injection, AbbVie, 22.5 mg (3 month), single dose administration kit, dual chamber prefilled syringe, 1 count, NDC 00074-3346-03
  • Lupron Depot intramuscular powder for suspension for injection, AbbVie, 30 mg (4 month), single dose administration kit, dual chamber prefilled syringe, 1 count, NDC 00074-3683-03
  • Lupron Depot intramuscular powder for suspension for injection, AbbVie, 45 mg (6 month), single dose administration kit, dual chamber prefilled syringe, 1 count, NDC 00074-3473-03
  • Lupron Depot intramuscular powder for suspension for injection, AbbVie, 7.5 mg (1 month), single dose administration kit, dual chamber prefilled syringe, 1 count, NDC 00074-3642-03

Implications for Patient Care

• • Lupron Depot 3.75 mg and 11.25 mg prefilled syringe kits are labeled for the management of endometriosis and for anemia, in combination with iron therapy, prior to uterine fibroid surgery.[1]
  • Lupron Depot 7.5 mg, 22.5 mg, 30 mg, and 45 mg prefilled syringe kits are labeled for the palliative treatment of advanced prostate cancer.[1]

References

• 1. Leuprolide. Lexi-Drugs Online. Hudson, OH: Lexi-Comp, Inc. 2019.